Due to its potential involvement in the beginning and advancement of cancer, as well as the fact that its aberrant expression is associated with clinical aspects such as metastasis, treatment resistance, and patient survival, NEAT1 exhibits characteristics of a tumor driver [27,28]. This evidence concerns the gene NEAT1 and neoplasm.